According to the news report, the device giant is ready to commit to an acquisition priced at “$10 million to something much more significant” in order to expand its offerings in minimally invasive surgery. The company has $221 million in cash and equivalents as of June 30.
More Articles on Orthopedic Devices:
RTI Biologics Reports $45.2M 2Q Revenue, Up 4%
